Cipher Pharmaceuticals Inc (CPH) — Capital Reinvestment Ratio
Cipher Pharmaceuticals Inc (CPH) has a Capital Reinvestment Ratio of 0.00x as of March 2026, meaning it reinvests 0% of its operating cash flow (CA$4.45 Million) in capital expenditures (CA$984.00). See how leveraged is Cipher Pharmaceuticals Inc's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cipher Pharmaceuticals Inc Capital Reinvestment Ratio (2010–2025)
This chart tracks Cipher Pharmaceuticals Inc's Capital Reinvestment Ratio across 14 annual periods. Check Cipher Pharmaceuticals Inc (CPH) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Cipher Pharmaceuticals Inc (2010–2025)
Year-by-year Capital Reinvestment Ratio for Cipher Pharmaceuticals Inc from 2010 to 2025. For live market cap and broader valuation context, see CPH market cap.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | CA$30.25 Million | CA$28.49K | ▼ -58.2% |
| 2024 | 0.00x | CA$19.55 Million | CA$44.00K | ▼ -75.0% |
| 2023 | 0.01x | CA$16.00 Million | CA$144.00K | ▲ +17.5% |
| 2022 | 0.01x | CA$10.57 Million | CA$81.00K | ▲ +30.6% |
| 2021 | 0.01x | CA$13.81 Million | CA$81.00K | ▼ -91.0% |
| 2020 | 0.07x | CA$11.69 Million | CA$760.00K | ▼ -56.1% |
| 2019 | 0.15x | CA$8.86 Million | CA$1.31 Million | ▼ -74.8% |
| 2018 | 0.59x | CA$11.28 Million | CA$6.63 Million | ▲ +5695.3% |
| 2017 | 0.01x | CA$19.93 Million | CA$202.00K | ▼ -81.6% |
| 2016 | 0.06x | CA$11.47 Million | CA$632.00K | ▼ -94.3% |
| 2015 | 0.97x | CA$7.76 Million | CA$7.57 Million | ▲ +48456.0% |
| 2013 | 0.00x | CA$7.02 Million | CA$14.09K | ▼ -98.3% |
| 2012 | 0.12x | CA$6.90 Million | CA$795.11K | ▼ -80.5% |
| 2010 | 0.59x | CA$1.24 Million | CA$735.88K | — |